Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Thales    HO   FR0000121329

THALES

(HO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thales : A long term support level to be taken advantage of

07/28/2020 | 03:47am EST
long trade on a pullback
Target price hit
Entry price : 62€ | Target : 69.2€ | Stop-loss : 58€ | Cancellation Level : 68€ | Potential : 11.61%
The decline over the past weeks has brought the price of Thales shares back to an important technical support level at 62 EUR. This represents an opportunity to take advantage of these prices levels.
Investors should buy the stock at current prices near € 62 in order to target the € 69.2.
Thales : Thales : A long term support level to be taken advantage of
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 62 EUR in weekly data.
  • Share prices are approaching a strong support area in daily data, which offers good timing for investors.
  • As regards fundamentals, the enterprise value to sales ratio is at 1 for the current period. Therefore, the company is undervalued.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Below the resistance at 82.6 EUR, the stock shows a negative configuration when looking looking at the weekly chart.

© MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2020 17 040 M 20 717 M 20 717 M
Net income 2020 717 M 872 M 872 M
Net Debt 2020 2 975 M 3 617 M 3 617 M
P/E ratio 2020 24,9x
Yield 2020 1,74%
Capitalization 15 568 M 18 880 M 18 927 M
EV / Sales 2020 1,09x
EV / Sales 2021 0,99x
Nbr of Employees 80 237
Free-Float 46,4%
Upcoming event on THALES
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 85,03 €
Last Close Price 73,20 €
Spread / Highest target 57,1%
Spread / Average Target 16,2%
Spread / Lowest Target -39,7%
EPS Revisions
Managers and Directors
NameTitle
Patrice Caine Chairman & Chief Executive Officer
Jean-Loïc Galle SEVP, Chief Operating & Performance Officer
Pascal Bouchiat CFO, Senior EVP-Finance & Information Systems
Philippe Keryer Executive VP-Strategy, Research & Technology
Charles Edelstenne Director
Sector and Competitors